SCHEMBL4058769

SCHEMBL4058769

C=C1C(=O)OC2C1CCC(C)C1(O)C=C(CO)C(=O)C21C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAX8 Q06710 1/20 0.55
▸ PTGS2 P35354 2/20 0.47
▸ PKM P14618 10/20 0.39
▸ NLRP3 Q96P20 2/20 0.32
▸ MAPT P10636 4/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ RECQL P46063 1/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ ALDH1A1 P00352 4/20 0.31
▸ LMNA P02545 3/20 0.31
▸ TP53 P04637 3/20 0.31
▸ CYP3A4 P08684 3/20 0.31
▸ NFKB1 P19838 2/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ STAT6 P42226 2/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4060824 0.78 PAX8 (0.51) PAX8PTGS2PKMNLRP3
Hymenin SCHEMBL11892893 0.77 PAX8 (0.58) PAX8PTGS2PKMNLRP3MAPT
Hymenin SCHEMBL29711376 0.77 PAX8 (0.58) PAX8PTGS2PKMNLRP3MAPT
Hymenin SCHEMBL12355327 0.77 PAX8 (0.58) PAX8PTGS2PKMNLRP3MAPT
Parthenin SCHEMBL382003 0.77 PAX8 (0.58) PAX8PTGS2PKMNLRP3MAPT
SCHEMBL4060819 0.77 PAX8 (0.50) PAX8PTGS2PKMNLRP3
SCHEMBL4379311 0.76 PAX8 (0.48) PAX8PTGS2NLRP3
SCHEMBL4379309 0.74 PAX8 (0.47) PAX8PTGS2NLRP3
Coronopilin SCHEMBL8422737 0.71 PAX8 (1.00) PAX8PTGS2PKMNLRP3MAPT
SCHEMBL4067330 0.70 PAX8 (0.61) PAX8PTGS2PKMNLRP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009122447-A1 SEMI-SYNTHETIC SESQUITERPENE LACTONE PARTHENIN COMPOUND USEFUL FOR CYTOTOXICITY AGAINST CANCER CELL LINES AND ANTICANDER AGENT COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2009-10-08 — — WO disclosed
Send feedback